1,288 results on '"Currier, Judith S"'
Search Results
202. Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIV
203. Audio Interview: Reinventing the Research Infrastructure to Address Covid-19
204. Comparative Pharmacokinetics of Tixagevimab/Cilgavimab ( AZD7442 ) Administered Intravenously Versus Intramuscularly in Symptomatic SARS‐CoV ‐2 Infection
205. Prevalence and factors associated with antigen test positivity following SARS-CoV-2 infection among healthcare workers in Los Angeles
206. Metabolic disease in HIV infection
207. Accelerating drug discovery for pregnant and lactating women living with HIV
208. Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19
209. Biomarkers of Microbial Translocation and Macrophage Activation: Association With Progression of Subclinical Atherosclerosis in HIV-1 Infection
210. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
211. A Pilot Trial of Adding Maraviroc to Suppressive Antiretroviral Therapy for Suboptimal CD4 + T-Cell Recovery Despite Sustained Virologic Suppression: ACTG A5256
212. Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine
213. In Memoriam: Scott M. Hammer, MD
214. Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection
215. Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
216. Availability of HIV Postexposure Prophylaxis Services in Los Angeles County
217. Lymphoma Diagnosis and Plasma Epstein-Barr Virus Load during Vicriviroc Therapy: Results of the AIDS Clinical Trials Group A5211
218. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma
219. Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19
220. Lower SARS-CoV-2 viral shedding following COVID-19 vaccination among healthcare workers in Los Angeles, California
221. COVID-19 Vaccination Rates in a Global HIV Cohort
222. Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platform
223. Prevalence and Factors Associated With Antigen Test Positivity Following SARS-CoV-2 Infection Among Health Care Workers in Los Angeles.
224. Incomplete Immune Reconstitution after Initiation of Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients with Severe CD4⁺ Cell Depletion
225. A Study of Discontinuing Maintenance Therapy in Human Immunodeficiency Virus-Infected Subjects with Disseminated Mycobacterium avium Complex: AIDS Clinical Trial Group 393 Study Team
226. Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding
227. Distinct lipidomic signatures in persons living with HIV: combined analysis of ACTG 5260s and MACS/WIHS
228. Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection
229. Indinavir, Nevirapine, Stavudine, and Lamivudine for Human Immunodeficiency Virus-Infected, Amprenavir-Experienced Subjects: AIDS Clinical Trials Group Protocol 373
230. The Effects of Protease Inhibitor Therapy on Human Immunodeficiency Virus Type 1 Levels in Semen (AIDS Clinical Trials Group Protocol 850)
231. Treatment with Amprenavir Alone or Amprenavir with Zidovudine and Lamivudine in Adults with Human Immunodeficiency Virus Infection
232. Coronary atherosclerotic lesions in human immunodeficiency virus–infected patients: a histopathologic study
233. Infectious Disease Rounds: Problems in the Management of Falciparum Malaria
234. Perioperative Antimicrobial Prophylaxis in Middle Tennessee, 1989-1990
235. Effects of HIV Infection on Arterial Endothelial Function: Results From a Large Pooled Cohort Analysis
236. Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection.
237. SARS-CoV-2 Infection after Vaccination in Health Care Workers in California
238. Endothelial Function in Human Immunodeficiency Virus-Infected Antiretroviral-Naive Subjects Before and After Starting Potent Antiretroviral Therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s
239. Calcification of the internal elastic lamina of coronary arteries
240. HIV and Atherosclerosis: Moving From Associations to Mechanisms and Interventions
241. Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus
242. Postexposure prophylaxis for HIV infection
243. Non-communicable Diseases in Pregnant and Postpartum Women Living with HIV: Implications for Health Throughout the Life Course
244. Effects of HIV Infection on Arterial Endothelial Function
245. Immune Biomarkers in the Prediction of Future Myocardial Infarctions in People With Human Immunodeficiency Virus
246. Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus-uninfected Individuals in HPTN 077
247. Management of Antiretroviral Treatment–Related Complications
248. Lipids, metabolic syndrome, and risk factors for future cardiovascular disease among HIV-infected patients
249. Sex differences in HIV: Natural history, pharmacokinetics, and drug toxicity
250. Getting smarter - the toxicity of undertreated HIV infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.